Through her pioneering research in the fields of immunoengineering and biomolecular engineering, Spangler aims to expand the repertoire of protein therapeutics for treating disease. Her current work focuses on redesigning naturally occurring proteins and engineering new molecules to overcome the deficiencies of existing drugs.